Skip to main content

Vext Science Inc(VEXT-CN)
CSE

Today's Change
Delayed Last Update
Day Low0.2750
Day High0.2750
Open:0.2750
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
Vext Announces Revised Date for Q4 and Fiscal 2025 Financial Results Release
Vext Science Announces Strategic Optimization of Arizona Operations and Plans for Ohio Cultivation Expansion
Vext Advances Ohio Expansion with Seventh Retail Location
Early Warning News Release of Jason T. Nguyen
Vext Announces Voting Results of Annual General Meeting
CORRECTION FROM SOURCE: Vext Reports Q3 2025 Financial Results
Vext Reports Q3 2025 Financial Results; Revenue Up 41% Year-over-Year and Operating Cash Flow Year-To-Date Reaches $8.5 Million
Vext to Announce Financial Results for Q3 2025 on November 20, 2025
Upcoming Meeting Dates - October 20, 2025
Vext Secures State Approval for Portsmouth Dispensary Ownership Transfer
Vext Announces Q2 2025 Financial Results: Record Quarterly Revenue with Strong 31% Cash Flow Margin
Vext to Announce Financial Results for Q2 2025 on August 20, 2025
Vext Continues Ohio Expansion with Sixth Dispensary Location in Fairfield
Vext Opens Fifth Ohio Dispensary in Portsmouth, Growing Retail Footprint in Key Ohio Market
Vext Announces Change of Auditor
Vext Delivers Record Q1 Performance: Achieves $3.1 Million in Operating Cash Flow on $11.6 Million in Revenue
Vext to Announce Financial Results for Q1 2025 on May 21, 2025
Vext Strengthens Balance Sheet and Sharpens Focus on Core Markets with Strategic Sale of Kentucky Medical Processing License
Vext Completes Ohio Expansion Transaction, Expanding Ohio Retail Presence to Four Dispensaries
Vext Delivers Solid Q4 Financial Results - Turning Point as Ohio Operations Gain Momentum
Vext to Announce Financial Results for Q4 and Fiscal 2024 on March 31, 2025
Vext Relocates and Expands Dispensary Located in Jackson, Ohio, Doubling Store's Retail Footprint
Vext Announces Voting Results of Annual General Meeting
Vext Secures Fifth Ohio Dispensary Location, Strengthening Retail Footprint
Vext Extends Engagement with Zuanic & Associates
Vext Provides Update on Annual General Meeting
Vext Reports Solid Financial Results for Q3 2024
Vext to Announce Financial Results for Q3 2024 on November 21, 2024
Vext Engages PartnerCap Securities, LLC
Vext Announces Financial Results for Q2 2024

Profile

Vext Science Inc provides management, advisory, cultivation, and dispensary services to entities in the medical cannabis field. The company's expertise spans from cultivation through to retail operations. Its revenue sources include management fees, professional services, product sales, equipment leasing and property leasing. The company's operations consist of a single operating segment engaged in the cultivation, manufacturing, distribution and sale of cannabis within the United States.